Abstract
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare mucocutaneous adverse drug reactions (Ferrandiz-Pulido and Garcia-Patos, 2013; Frey et al., 2017a, 2017b; Harr and French, 2012; Hsu et al., 2016; Martín-Merino et al., 2015; Mockenhaupt, 2012; Mockenhaupt et al., 2005). In the European Registry of Severe Cutaneous Adverse Reactions, 23% of patients died within 6 weeks after the onset of SJS and/or TEN (SJS: 12%, SJS and TEN overlap: 29%, TEN: 46%, 2003–2007). After 1 year, 34% of patients had died (Sekula et al., 2013).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
